Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20
Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20
富國銀行以增持評級啓動對Ironwood Pharmicals的報道,宣佈目標股價爲20美元
Wells Fargo analyst Mohit Bansal initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight rating and announces Price Target of $20.
富國銀行分析師莫希特·班薩爾以增持評級開始對艾恩伍德製藥(納斯達克股票代碼:IRWD)進行報道,並宣佈目標股價爲20美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。